How does obesity affect pharmacokinetics and what dosing considerations arise?

• A. Reduces volume of distribution for lipophilic drugs and increases clearance.
• B. Increases volume of distribution for lipophilic drugs and can alter clearance; may require higher initial doses or altered regimens.
• C. Has no effect on pharmacokinetics.
• D. Always decreases half-life.

Answer: (B)